2019
DOI: 10.1172/jci.insight.122912
|View full text |Cite|
|
Sign up to set email alerts
|

C3a and suPAR drive versican V1 expression in tubular cells of focal segmental glomerulosclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
20
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 28 publications
(21 citation statements)
references
References 68 publications
(75 reference statements)
1
20
0
Order By: Relevance
“…XAV-939, a selective inhibitor to Wnt/β-catenin signaling pathway by tankyrase1/2 inhibition (14,35), could upregulate the expression of CNPase, PLP, MBP, MAG, CC1, Olig1, Olig2 and SOX10 and decrease the expression of NG2 in OPCs treated with C3a. As reported by Han, C3a could lead to a significant phosphorylation of AKT and the nuclear accumulation of β-catenin in tubular cells (33). Phosphorylated AKT can activate β-catenin/TCF4 transcriptional activity by the indirect stabilization of β-catenin through GSK-3β inhibition and by directly inhibiting the phosphorylation of β-catenin (53).…”
Section: Discussionmentioning
confidence: 82%
“…XAV-939, a selective inhibitor to Wnt/β-catenin signaling pathway by tankyrase1/2 inhibition (14,35), could upregulate the expression of CNPase, PLP, MBP, MAG, CC1, Olig1, Olig2 and SOX10 and decrease the expression of NG2 in OPCs treated with C3a. As reported by Han, C3a could lead to a significant phosphorylation of AKT and the nuclear accumulation of β-catenin in tubular cells (33). Phosphorylated AKT can activate β-catenin/TCF4 transcriptional activity by the indirect stabilization of β-catenin through GSK-3β inhibition and by directly inhibiting the phosphorylation of β-catenin (53).…”
Section: Discussionmentioning
confidence: 82%
“…V2 is only expressed in the central neuron system ( Wight et al, 2014a , b ; Wight, 2017 ). In previous studies of CKD, versican has been discovered as a predictor of disease progression, but there is no study focusing on the influence of versican on DKD tubulointerstitium ( Rudnicki et al, 2012 ; Han et al, 2019 ; Taylor et al, 2020 ).…”
Section: Discussionmentioning
confidence: 99%
“…As C57BL/6 mice are resistant to ADR-induced nephropathy ( Lee and Harris, 2011 ), ADR nephropathy was induced by injection of 10.5 mg/kg ADR (D1515; Sigma-Aldrich) via the tail vein in BALB/c male mice at age 10–12 wk ( Han et al, 2019 ), and mice were sacrificed at 4 wk after injection. DN was induced in C57BL/6 male mice aged 8 wk by intraperitoneal injection with streptozotocin (STZ; 50 µg/g; S0130; Sigma-Aldrich) for 5 d consecutively.…”
Section: Methodsmentioning
confidence: 99%